5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive genomic profiling of 113 patients with advanced renal cell carcinoma
    Meeting Abstract

    Gedvilaite, E.; Kotecha, R.; Murray, S.; Foster, A.; Motzer, R.; Ptashkin, R.; Johnson, I.; Shah, R.; Dunigan, M.; Huberman, K.; more...
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • A phase 3 study (Cosmic-313) of cabozantinib in combination with nivolumab and ipilimumab in patients with previously untreated advanced renal cell carcinoma of intermediate or poor risk
    Meeting Abstract

    Choueiri, T.; Albiges, L.; Powles, T.; Mohamed, N.; Wang, F.; Motzer, R.
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Phase 1 study of AMG 160, a half-life extended BiTE(R) (Bispecific T-cell engager) therapy targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer
    Meeting Abstract

    Dorff, T.; Rettig, M.; Machiels, J. P.; Lolkema, M.; Autio, K.; Greil, R.; Rottey, S.; Adra, N.; Salvati, M.; Poon, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • CTLA-4 blockade promotes Treg glucose metabolism and reduces Treg functional stability in glycolysis-defective tumors
    Meeting Abstract

    Zappasodi, R.; Serganova, I.; Cohen, I.; Maeda, M.; Senbabaoglu, Y.; Shindo, M.; Maniyar, R.; Mane, M.; Leftin, A.; Watson, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors
    Journal Article

    Razavi, P.; Dickler, M. N.; Shah, P. D.; Toy, W.; Brown, D. N.; Won, H. H.; Li, B. T.; Shen, R.; Vasan, N.; Modi, S.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Use of positron emission tomography imaging: Another nonbiological source of racial disparities in US cancer care
    Editorial

    Mitchell, A. P.; Bach, P. B.
    JNCI: Journal of the National Cancer Institute (2020)

    Fulltext@MSK | Save
  • Comparative survival of Asian and White metastatic castration-resistant prostate cancer men treated with docetaxel
    Journal Article

    Halabi, S.; Dutta, S.; Tangen, C. M.; Rosenthal, M.; Petrylak, D. P.; Thompson, I. M. Jr; Chi, K. N.; De Bono, J. S.; Araujo, J. C.; Logothetis, C.; more...
    JNCI Cancer Spectrum (2020)

    Fulltext@MSK | Save
  • Cardiovascular safety of degarelix versus leuprolide for advanced prostate cancer: The PRONOUNCE trial study design
    Journal Article

    Melloni, C.; Slovin, S. F.; Blemings, A.; Goodman, S. G.; Evans, C. P.; Nilsson, J.; Bhatt, D. L.; Zubovskiy, K.; Olesen, T. K.; Dugi, K.; more...
    JACC: CardioOncology (2020)

    Fulltext@MSK | Save
  • Clinical and genome-wide analysis of multiple severe cisplatin-induced neurotoxicities in adult-onset cancer survivors
    Journal Article

    Trendowski, M. R.; Wheeler, H. E.; El-Charif, O.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Fung, C.; Kollmannsberger, C.; Einhorn, L. H.; Travis, L. B.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Dual blockade of c-MET and the androgen receptor in metastatic castration-resistant prostate cancer: A phase I study of concurrent enzalutamide and crizotinib
    Journal Article

    Tripathi, A.; Supko, J. G.; Gray, K. P.; Melnick, Z. J.; Regan, M. M.; Taplin, M. E.; Choudhury, A. D.; Pomerantz, M. M.; Bellmunt, J.; Yu, C.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save